Attached files

file filename
EX-99.2 - NEWS RELEASE DATED SEPTEMBER 7, 2012 - LIBERTY STAR URANIUM & METALS CORP.exhibit99-2.htm
EX-99.1 - NEWS RELEASE DATED SEPTEMBER 6, 2012 - LIBERTY STAR URANIUM & METALS CORP.exhibit99-1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) August 28, 2012
 
LIBERTY STAR URANIUM & METALS CORP.
(Exact name of registrant as specified in its charter)

Nevada 000-50071 90-0175540
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

5610 E. Sutler Lane, Tucson, Arizona 85712
(Address of principal executive offices and Zip Code)

Registrant’s telephone number, including area code 520-731-8786

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective August 28, 2012, Charles Vollmer resigned as a director of our company.

Effective September 6, 2012, we appointed Peter O’Heeron as a director of our company.

Mr. O’Heeron leads an operational investment group which identifies early stage opportunities in the medical field with strong intellectual property positions. Through his 20+ years of medical product development experience, Mr. O’Heeron brings together the resources from strategic disciplines necessary to commercialize unique technologies. Prior to founding Advanced Medical Technologies LLC, Mr. O’Heeron founded NeoSurg Technologies, Inc. to develop a minimally invasive access system. As a result of his efforts, NeoSurg Technologies was successful in developing the T2000 Minimally Invasive Access System, the world leader in reposable surgical instrumentation. Mr. O’Heeron completed the sale of NeoSurg Technologies to CooperSurgical in 2005. Mr. O’Heeron graduated from Texas State University with a BS in Healthcare Administration and a minor in Business Administration. He received his Masters in Healthcare Administration from the University of Houston. Mr. O’Heeron currently holds 5 patents and has 4 patents pending.

Family Relationships

No family relationships exist between any of our directors or executive officers.

Certain Related Transactions and Relationships

We have not been party to any transaction with Mr. O’Heeron since the beginning of our last fiscal year, or any currently proposed transaction with Mr. O’Heeron in which we were or will be a participant and where the amount involved exceeds $120,000, and in which Mr. O’Heeron had or will have a direct or indirect material interest.

Item 8.01 Other Events

The Company announced an update on its scout drilling program at Big Chunk, Alaska. A copy of our news release dated September 7, 2012 is furnished herewith.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits
   
99.1 News Release dated September 6, 2012.
99.2 News Release dated September 7, 2012.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LIBERTY STAR URANIUM & METALS CORP.

By: /s/ James Briscoe  
James Briscoe, Chief Executive Officer and Director  
Date: September 4, 2012